RESTATEMENT OF PREVIOUSLY ISSUED QUARTERLY FINANCIAL STATEMENTS - RESTATED CONSOLIDATED STATEMENTS OF OPERATIONS (Details) - USD ($) |
3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 |
Jun. 30, 2023 |
Mar. 31, 2023 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Mar. 31, 2022 |
Jun. 30, 2023 |
Jun. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
OPERATING EXPENSES: | ||||||||||||
Research and development | $ 7,034,656 | $ 6,135,010 | $ 6,359,256 | $ 5,210,825 | $ 4,144,918 | $ 3,703,831 | $ 12,494,266 | $ 27,266,276 | $ 18,265,711 | |||
Research and development | $ 7,848,709 | $ 19,528,898 | $ 13,059,534 | |||||||||
General and administrative | 2,378,804 | 2,158,992 | 2,346,045 | 2,604,661 | 3,290,606 | 2,436,396 | 4,505,037 | 11,694,367 | 10,548,062 | |||
General and administrative | 5,727,042 | 6,883,866 | 8,331,703 | |||||||||
Total operating expenses | 9,413,460 | 8,294,002 | 8,705,301 | 7,815,486 | 7,435,524 | 6,140,227 | 16,999,303 | 13,575,751 | 26,412,764 | 21,391,237 | 38,960,643 | 28,813,773 |
LOSS FROM OPERATIONS | (9,413,460) | (8,294,002) | (8,705,301) | (7,815,486) | (7,435,524) | (6,140,227) | (16,999,303) | (13,575,751) | (26,412,764) | (21,391,237) | (38,960,643) | (28,813,773) |
OTHER INCOME (EXPENSE): | ||||||||||||
Warrant issuance expense | (470,000) | (470,000) | (470,000) | (6,824,605) | ||||||||
(Loss) gain on valuation of warrants | (7,688,028) | (1,957,418) | 1,390,797 | 300,000 | 1,800,000 | (100,000) | (566,621) | 1,700,000 | (8,254,649) | 2,000,000 | (3,787,114) | 3,633,241 |
Interest income | 51,110 | 72,780 | 124,034 | 4,164 | 481 | 430 | 196,814 | 911 | 247,925 | 5,075 | 387,147 | 152,519 |
Total other income (expense), net | (8,106,918) | (1,884,638) | 1,514,831 | 304,164 | 1,800,481 | (99,570) | (369,807) | 1,700,911 | (8,476,724) | 2,005,075 | (3,869,967) | (3,038,845) |
NET LOSS | $ (17,520,378) | $ (10,178,640) | $ (7,190,470) | $ (7,511,322) | $ (5,635,043) | $ (6,239,797) | $ (17,369,110) | $ (11,874,840) | $ (34,889,488) | $ (19,386,162) | $ (42,770,610) | $ (31,792,618) |
BASIC NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE | $ (1.55) | $ (0.90) | $ (0.64) | $ (1.23) | $ (0.92) | $ (1.02) | $ (1.54) | $ (1.94) | $ (3.09) | $ (3.17) | $ (3.50) | $ (4.51) |
DILUTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE | $ (1.55) | $ (0.90) | $ (0.64) | $ (1.23) | $ (0.92) | $ (1.02) | $ (1.54) | $ (1.94) | $ (3.09) | $ (3.17) | $ (3.50) | $ (4.51) |
SHARES USED IN COMPUTING BASIC NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE | 11,308,738 | 11,261,217 | 11,261,217 | 6,110,119 | 6,110,124 | 6,110,126 | 11,261,217 | 6,110,125 | 11,277,231 | 6,110,123 | 12,221,571 | 7,055,665 |
SHARES USED IN COMPUTING DILUTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE | 11,308,738 | 11,261,217 | 11,261,217 | 6,110,119 | 6,110,124 | 6,110,126 | 11,261,217 | 6,110,125 | 11,277,231 | 6,110,123 | 12,221,571 | 7,055,665 |
As previously reported | ||||||||||||
OPERATING EXPENSES: | ||||||||||||
Research and development | $ 7,312,504 | $ 6,308,430 | $ 6,654,094 | $ 5,380,190 | $ 4,498,657 | $ 3,887,039 | $ 12,962,524 | $ 28,211,460 | $ 19,219,603 | |||
Research and development | $ 8,385,656 | $ 20,275,004 | $ 13,765,846 | |||||||||
General and administrative | 2,100,956 | 1,985,572 | 2,051,207 | 2,435,296 | 2,936,867 | 2,253,188 | 4,036,779 | 10,749,183 | 9,594,170 | |||
General and administrative | 5,190,095 | 6,137,760 | 7,625,391 | |||||||||
Total operating expenses | 9,413,460 | 8,294,002 | 8,705,301 | 7,815,486 | 7,435,524 | 6,140,227 | 16,999,303 | 13,575,751 | 26,412,764 | 21,391,237 | 38,960,643 | 28,813,773 |
LOSS FROM OPERATIONS | (9,413,460) | (8,294,002) | (8,705,301) | (7,815,486) | (7,435,524) | (6,140,227) | (16,999,303) | (13,575,751) | (26,412,764) | (21,391,237) | (38,960,643) | (28,813,773) |
OTHER INCOME (EXPENSE): | ||||||||||||
Warrant issuance expense | (470,000) | (470,000) | (470,000) | |||||||||
(Loss) gain on valuation of warrants | (3,900,000) | (3,900,000) | 1,000,000 | |||||||||
Interest income | 51,110 | 72,780 | 124,034 | 4,164 | 481 | 430 | 196,814 | 911 | 247,925 | 5,075 | 387,147 | 152,519 |
Total other income (expense), net | (4,318,890) | 72,780 | 124,034 | 4,164 | 481 | 430 | 196,814 | 911 | (4,122,075) | 5,075 | 917,147 | 152,519 |
NET LOSS | $ (13,732,350) | $ (8,221,222) | $ (8,581,267) | $ (7,811,322) | $ (7,435,043) | $ (6,139,797) | $ (16,802,489) | $ (13,574,840) | $ (30,534,839) | $ (21,386,162) | $ (37,983,496) | $ (28,601,254) |
BASIC NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE | $ (1.21) | $ (0.73) | $ (0.76) | $ (1.28) | $ (1.22) | $ (1.00) | $ (1.49) | $ (2.22) | $ (2.71) | $ (3.50) | $ (3.11) | $ (4.05) |
DILUTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE | $ (1.21) | $ (0.73) | $ (0.76) | $ (1.28) | $ (1.22) | $ (1.00) | $ (1.49) | $ (2.22) | $ (2.71) | $ (3.50) | $ (3.11) | $ (4.05) |
SHARES USED IN COMPUTING BASIC NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE | 11,308,738 | 11,261,217 | 11,261,217 | 6,110,119 | 6,110,124 | 6,110,126 | 11,261,217 | 6,110,125 | 11,277,231 | 6,110,123 | 12,221,571 | 7,055,665 |
SHARES USED IN COMPUTING DILUTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE | 11,308,738 | 11,261,217 | 11,261,217 | 6,110,119 | 6,110,124 | 6,110,126 | 11,261,217 | 6,110,125 | 11,277,231 | 6,110,123 | 12,221,571 | 7,055,665 |
Restatement adjustments | ||||||||||||
OPERATING EXPENSES: | ||||||||||||
Research and development | $ (277,848) | $ (173,420) | $ (294,838) | $ (169,365) | $ (353,739) | $ (183,208) | $ (468,258) | $ (945,184) | $ (953,892) | |||
Research and development | $ (536,947) | $ (746,106) | $ (706,312) | |||||||||
General and administrative | 277,848 | 173,420 | 294,838 | 169,365 | 353,739 | 183,208 | 468,258 | 945,184 | 953,892 | |||
General and administrative | 536,947 | 746,106 | 706,312 | |||||||||
OTHER INCOME (EXPENSE): | ||||||||||||
Warrant issuance expense | (6,824,605) | |||||||||||
(Loss) gain on valuation of warrants | (3,788,028) | (1,957,418) | 1,390,797 | 300,000 | 1,800,000 | (100,000) | (566,621) | 1,700,000 | (4,354,649) | 2,000,000 | (4,787,114) | 3,633,241 |
Total other income (expense), net | (3,788,028) | (1,957,418) | 1,390,797 | 300,000 | 1,800,000 | (100,000) | (566,621) | 1,700,000 | (4,354,649) | 2,000,000 | (4,787,114) | (3,191,364) |
NET LOSS | $ (3,788,028) | $ (1,957,418) | $ 1,390,797 | $ 300,000 | $ 1,800,000 | $ (100,000) | $ (566,621) | $ 1,700,000 | $ (4,354,649) | $ 2,000,000 | $ (4,787,114) | $ (3,191,364) |
BASIC NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE | $ (0.33) | $ (0.17) | $ 0.12 | $ 0.05 | $ 0.29 | $ (0.02) | $ (0.05) | $ 0.28 | $ (0.39) | $ 0.33 | $ (0.39) | $ (0.45) |
DILUTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE | $ (0.33) | $ (0.17) | $ 0.12 | $ 0.05 | $ 0.29 | $ (0.02) | $ (0.05) | $ 0.28 | $ (0.39) | $ 0.33 | $ (0.39) | $ (0.45) |